Pilot Study of Video and Telephone Primary Care Visits

February 8, 2022 updated by: Johns Hopkins University

Pilot Study - Randomized Controlled Trial of Video and Telephone Primary Care Visits

The inability to access and use smartphones or camera-outfitted internet-connected devices during the COVID-19 pandemic relegates certain patients to receive audio-only telemedicine instead of audio/video-based telemedicine. The investigators are conducting a randomized controlled trial in order to characterize patient and provider attitudes towards these two modalities of care and to test the feasibility of a new model to make tablets for video-based care accessible to those who need that. The investigators hypothesize that patient and provider satisfaction will be higher with video-based telehealth when compared to phone-based telehealth.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21287
        • Johns Hopkins Outpatient Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients scheduled for telephone-based visits who are doing so because of a lack of ability to conduct a video visit (i.e. no tablet/laptop; no access to internet) who live in Baltimore City

Exclusion Criteria:

  • Patients with significant visual or hearing impairment
  • Patients that have legal guardians or who are marked as lacking healthcare decision-making capacity
  • Patients that have not selected English as their preferred language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Telemedicine - Phone
Patients will continue with their telephone-based telemedicine visit as scheduled. There will be no change to their care. Patients will receive a survey by mail about the visit.
Experimental: Telemedicine - Audio/Video
Patients will be given an internet-connected tablet to have their upcoming visit with their physician by audio/video. A survey can be completed on the tablet. The devices will be sent back to the research time after their single use.
An internet-connected tablet provided to patient for upcoming visit with physician by audio/video which can also be used to complete a survey.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Provider rating as assessed by the Consumer Assessment of Healthcare Providers and Systems question on provider rating
Time Frame: Within 2 weeks of the study visit
Provider rating will be assessed with the Consumer Assessment of Healthcare Providers and Systems question on provider rating of 0-10; 0 being worst provider possible and 10 being best provider possible.
Within 2 weeks of the study visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction with telemedicine visit for patient as assessed by a Likert scale
Time Frame: Within 2 weeks of the study visit

Satisfaction with telemedicine visit for patient will be assessed with Likert-scale questions related to satisfaction.

Satisfaction (1=strongly disagree to 5=strongly agree).

  1. In general, I was satisfied with using a video or phone call for this visit
  2. I could explain my medical problems well enough
  3. Talking to the doctor was as satisfying as talking in person

Overall score 3 to 15 with higher scores signifying better satisfaction.

Within 2 weeks of the study visit
Satisfaction with telemedicine visit for provider as assessed by a Likert scale
Time Frame: Within 2 weeks of the study visit

Satisfaction with telemedicine visit for provider will be assessed with Likert-scale questions related to satisfaction.

[1=Strongly Disagree. 5=Strongly Agree].

  1. In general, I was satisfied with using telemedicine for this visit
  2. Talking to the patient was as satisfying as talking in person.

Overall score 2 to 10 with higher scores signifying better satisfaction.

Within 2 weeks of the study visit
Efficacy of telemedicine visit for provider as assessed by a Likert scale
Time Frame: Within 2 weeks of the study visit

Efficacy of telemedicine visit for provider will be assessed with Likert-scale questions related to efficacy.

[1=Strongly Disagree. 5=Strongly Agree]. b. I was able to understand the patient's explanation of their medical problems well enough.

c. In general, this telemedicine visit was effective in improving this patient's medical care d. An in-person visit would likely have provided additional clinically-relevant information e. An in-person visit would likely have led to a change in management

Within 2 weeks of the study visit
Provider communication as assessed by yes/no question
Time Frame: Within 2 weeks of the study visit

The ability of a provider to communicate will be assessed by patients with the yes/no question of a modified version of the Consumer Assessment of Healthcare Providers and Systems questionnaire related to communication.

Did this provider explain things in a way that was easy to understand? Yes/No

Within 2 weeks of the study visit
Provider listening as assessed by yes/no question
Time Frame: Within 2 weeks of the study visit

Provider listening will be assessed by patients with the yes/no question of a modified version of the Consumer Assessment of Healthcare Providers and Systems questionnaire related to listening.

Did this provider listen carefully to you? Yes/No

Within 2 weeks of the study visit
Provider respect as assessed by yes/no question
Time Frame: Within 2 weeks of the study visit

Provider respect will be assessed by patients with the yes/no question of a modified version of the Consumer Assessment of Healthcare Providers and Systems questionnaire relating to respect.

Did this provider show respect for what you had to say? Yes/No

Within 2 weeks of the study visit
Provider time spent as assessed by yes/no question
Time Frame: Within 2 weeks of the study visit

Provider time spent will be assessed by patients with the yes/no question of a modified version of the Consumer Assessment of Healthcare Providers and Systems questionnaire relating to time spent during the clinical encounter.

Did this provider spend enough time with you? Yes/No

Within 2 weeks of the study visit
Patient health rating as assessed by a likert scale
Time Frame: Within 2 weeks of the study visit

Patient health will be assessed with Likert-scale questions related to patient health.

In general, how would you rate your overall health?

  1. Excellent
  2. Very good
  3. Good
  4. Fair
  5. Poor

In general, how would you rate your overall mental or emotional health?

  1. Excellent
  2. Very good
  3. Good
  4. Fair
  5. Poor

Overall score 2 to 10 with lower scores signifying better health.

Within 2 weeks of the study visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeremy A Epstein, MD, Johns Hopkins University
  • Principal Investigator: Casey Overby Taylor, PhD, Johns Hopkins University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 24, 2021

Primary Completion (Actual)

November 24, 2021

Study Completion (Actual)

December 30, 2021

Study Registration Dates

First Submitted

July 29, 2020

First Submitted That Met QC Criteria

July 29, 2020

First Posted (Actual)

August 3, 2020

Study Record Updates

Last Update Posted (Actual)

February 9, 2022

Last Update Submitted That Met QC Criteria

February 8, 2022

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00257994

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Protocol and analysis plan, without any protected health information (PHI), can be shared on request via email.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telemedicine

Clinical Trials on Internet-connected computer tablet

3
Subscribe